Federal Awards · Award

DHA STTR PHASE II PROPOSAL H2-0803, TITLED "DEVELOPMENT OF ANTIBODY TREATMENT OF MDR ESKAPE PATHOGEN, P. AE…

Award details are derived from public USAspending.gov records. Not a bid recommendation.

Award details

Award ID
HT942525C0011
Contractor
Awarding agency
Department of Defense
Sub-agency / office
Defense Health Agency
Award amount
$1,299,972
Period of performance
Mar 12, 2025 – Jul 11, 2027
NAICS
541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC
PSC AN12
Place of performance
TX

Public award description

DHA STTR PHASE II PROPOSAL H2-0803, TITLED "DEVELOPMENT OF ANTIBODY TREATMENT OF MDR ESKAPE PATHOGEN, P. AERUGINOSA.", MEDICAL R&D CONTRACT.

Source: USAspending.gov

Find out who's winning similar federal contracts

Discover comparable awards, related contractors, and agency purchasing history.

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. Click Gemini to copy the research question when your browser allows, or use Copy question.